Exclusive Enteral Nutritional Therapy Can Relieve Inflammatory Bowel Stricture in Crohn’s Disease

Goals: To examine the efficiency of exclusive enteral nutrition (EEN) in relieving inflammatory bowel stricture in patients with Crohn’s disease (CD). Background: Patients with CD usually develop bowel strictures due to transmural edema of intestinal wall, which can potentially be managed with conservative medical treatment. Previous studies showed that EEN therapy could induce clinical remission through its anti-inflammation effect. Methods: We achieved a prospective observational study. CD patients with inflammatory bowel stricture were preliminarily differentiated from a fibrous one, and further treated with EEN therapy for 12 weeks. Demographics and clinical variables were recorded. Nutritional (body mass index, albumin, pre-albumin, transferrin, etc.), inflammatory (C-reactive protein, erythrocyte sedimentation rate, white blood cell, etc.), and radiologic parameters (bowel wall thickness, luminal diameter, and luminal cross-sectional area) were evaluated at baseline, week 4, and week 12, respectively. Results: Between May 2012 and January 2013, 65 patients with CD were preliminarily diagnosed with inflammatory bowel stricture and 6 patients were further excluded. Among the remaining 59 cases, 50 patients (84.7%) finished the whole EEN treatment, whereas the other 9 patients (15.3%) gained progressive bowel obstruction resulting in surgery. Intention-to-treat analyses showed that 48 patients (81.4%) achieved symptomatic remission, 35 patients (53.8%) achieved radiologic remission, and 42 patients (64.6%) achieved clinical remission. Among those patients who complete the whole EEN therapy, inflammatory, nutritional, and radiologic parameters improved significantly compared with baseline. Of note, the average luminal cross-sectional area at the site of stricture increased approximately 331% at week 12 (195.7±18.79 vs. 59.09±10.64 mm2, P<0.001). Conclusions: EEN therapy can effectively relieve inflammatory bowel stricture in CD, which replenishes roles of enteral nutrition in the treatment of CD. Further studies are expected to investigate the underlying mechanisms of this effect in the future.

[1]  A. Otley,et al.  Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. , 2012, Journal of pediatric gastroenterology and nutrition.

[2]  L. Peyrin-Biroulet,et al.  The Natural History of Adult Crohn's Disease in Population-Based Cohorts , 2010, The American Journal of Gastroenterology.

[3]  M. Nakahigashi,et al.  Impacts of long‐term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study , 2007, Inflammatory bowel diseases.

[4]  Y. Chowers,et al.  The patient with recurrent (sub) obstruction due to Crohn's disease. , 2007, Best practice & research. Clinical gastroenterology.

[5]  N. Docherty,et al.  Fibrogenesis in Crohn's Disease , 2007, The American Journal of Gastroenterology.

[6]  S. Kuriyama,et al.  Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn's disease: a randomized‐controlled trial , 2006, Alimentary pharmacology & therapeutics.

[7]  A. Day,et al.  Exclusive enteral feeding as primary therapy for Crohn’s disease in Australian children and adolescents: A feasible and effective approach , 2006, Journal of gastroenterology and hepatology.

[8]  X. Dray,et al.  The use of enteral nutrition in the management of Crohn's disease in adults. , 2005, JPEN. Journal of parenteral and enteral nutrition.

[9]  A. Fichera,et al.  Long-Term Outcome of Surgically Treated Crohn’s Colitis: A Prospective Study , 2005, Diseases of the colon and rectum.

[10]  B. Burnand,et al.  Obstructive Fibrostenotic Crohn’s Disease , 2005, Digestion.

[11]  M. Savage,et al.  Anti-Inflammatory and Growth-Stimulating Effects Precede Nutritional Restitution During Enteral Feeding in Crohn Disease , 2004, Journal of pediatric gastroenterology and nutrition.

[12]  P. Rutgeerts,et al.  Medical Therapy for Crohn's Disease Strictures , 2004, Inflammatory bowel diseases.

[13]  S. Verma,et al.  Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. , 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[14]  M. Corey,et al.  Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. , 1996, Gut.

[15]  A. Griffiths,et al.  Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. , 1995, Gastroenterology.

[16]  A. Segal,et al.  Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. , 1984, British medical journal.

[17]  P. Rutgeerts,et al.  Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. , 1984, Gut.

[18]  B. Korelitz,et al.  Prognosis for nonoperative management of small-bowel obstruction in Crohn's disease. , 1983, Journal of Clinical Gastroenterology.

[19]  M. K. Younoszai Growth in a teenage boy with granulomatous enteritis fed "elemental diets". , 1977, American journal of diseases of children.

[20]  S. Bank,et al.  The use of an elemental diet in gastro-intestinal diseases. , 1976, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[21]  R. Farmer,et al.  Indications for surgery in Crohn's disease: analysis of 500 cases. , 1976, Gastroenterology.

[22]  V. Echavé,et al.  Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? , 1973, Archives of surgery.

[23]  Malfertheiner,et al.  World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. , 2010, Inflammatory bowel diseases.

[24]  B. Vucelić,et al.  Obstruction in Crohn's disease , 2009 .

[25]  G. Van den Berghe,et al.  ESPEN Guidelines on Enteral Nutrition: Intensive care. , 2006, Clinical nutrition.